Literature DB >> 19156472

Factors associated with the use of preventive care for contrast-induced acute kidney injury.

Steven D Weisbord1, Maria K Mor, Sunghee Kim, Kathryn C Hartwig, Ali F Sonel, Paul M Palevsky, Michael J Fine.   

Abstract

BACKGROUND: The factors that affect the implementation of preventive care for contrast-induced acute kidney injury (CIAKI) are unknown.
OBJECTIVE: To assess patient and provider factors associated with the use of preventive care for CIAKI.
DESIGN: Prospective cohort study. PARTICIPANTS: Patients with kidney disease undergoing procedures with intravascular iodinated radiocontrast. MEASUREMENTS: We recorded the use of preventive care defined as the administration of: (1) pre- and post-procedure isotonic intravenous (IV) fluid, (2) N-acetylcysteine, and (3) iso-osmolal radiocontrast. We surveyed patients' providers to assess their knowledge, experience, and training on CIAKI and used multiple logistic regression to assess the independent associations of patient and provider factors with the use of these preventive interventions.
RESULTS: We enrolled 660 patients and 87 providers. Patient factors associated with use of IV fluid and N-acetylcysteine were higher baseline serum creatinine (OR 1.5 and 5.0, p < 0.05) and inpatient status (OR 3.0 and 6.3, p < 0.05), while higher baseline serum creatinine was associated with the use of iso-osmolal contrast (OR = 13.4, p < 0.01). The primary provider characteristics associated with the use of IV fluid and N-acetylcysteine were a greater degree of prior training on CIAKI (OR 1.9 and 2.8, p < 0.05) and higher number of prior patients with CIAKI (OR 2.7 and 2.6, p < 0.05).
CONCLUSIONS: Patient baseline kidney function and provider training and experience with CIAKI are independently associated with the use of preventive care. Efforts to increase and intensify the training providers receive on CIAKI may help decrease the incidence of this costly iatrogenic condition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19156472      PMCID: PMC2642579          DOI: 10.1007/s11606-008-0894-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  26 in total

1.  A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity.

Authors:  Hariprasad S Trivedi; Harold Moore; Samer Nasr; Kul Aggarwal; Alok Agrawal; Punit Goel; John Hewett
Journal:  Nephron Clin Pract       Date:  2003-01

2.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Authors:  M Tepel; M van der Giet; C Schwarzfeld; U Laufer; D Liermann; W Zidek
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

3.  Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents.

Authors:  R Solomon; C Werner; D Mann; J D'Elia; P Silva
Journal:  N Engl J Med       Date:  1994-11-24       Impact factor: 91.245

4.  Prevention of nephrotoxicity induced by radiocontrast agents.

Authors:  B J Barrett; P S Parfrey
Journal:  N Engl J Med       Date:  1994-11-24       Impact factor: 91.245

5.  Nephrotoxic effects in high-risk patients undergoing angiography.

Authors:  Peter Aspelin; Pierre Aubry; Sven-Göran Fransson; Ruth Strasser; Roland Willenbrock; Knut Joachim Berg
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

6.  Prevention, incidence, and outcomes of contrast-induced acute kidney injury.

Authors:  Steven D Weisbord; Maria K Mor; Abby L Resnick; Kathryn C Hartwig; Ali F Sonel; Michael J Fine; Paul M Palevsky
Journal:  Arch Intern Med       Date:  2008-06-23

7.  Acetylcysteine for prevention of contrast nephropathy: meta-analysis.

Authors:  Rainer Birck; Stefan Krzossok; Florian Markowetz; Peter Schnülle; Fokko J van der Woude; Claude Braun
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

8.  Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials.

Authors:  Alvaro Alonso; Joseph Lau; Bertrand L Jaber; Andrew Weintraub; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2004-01       Impact factor: 8.860

9.  Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure.

Authors:  Kou Gi Shyu; Jun Jack Cheng; Peiliang Kuan
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094

10.  Provider use of preventive strategies for radiocontrast nephropathy in high-risk patients.

Authors:  Steven D Weisbord; Frank J Bruns; Melissa I Saul; Paul M Palevsky
Journal:  Nephron Clin Pract       Date:  2004
View more
  2 in total

1.  Development and Evaluation of an Audit and Feedback Process for Prevention of Acute Kidney Injury During Coronary Angiography and Intervention.

Authors:  Bryan Ma; Peter Faris; Bryan J Har; Ben Tyrrell; Eleanor Benterud; John A Spertus; Neesh Pannu; Braden J Manns; Michelle M Graham; Matthew T James
Journal:  CJC Open       Date:  2021-10-23

Review 2.  Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence.

Authors:  Swapnil Hiremath; Ayub Akbari; Wael Shabana; Dean A Fergusson; Greg A Knoll
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.